Celltrion
068270.KS
#722
Rank
S$37.64 B
Marketcap
$183.18
Share price
0.98%
Change (1 day)
-1.02%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Net assets

Net assets on the balance sheet as of September 2024 : S$17.55 Billion

According to Celltrion 's latest financial reports the company has S$17.55 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Celltrion - Net assets on balance sheet (from 2007 to 2024)

Net assets by year

Year Net assets Change
2022-12-31$S$4.54 B-1.25%
2021-12-31$S$4.60 B10.26%
2020-12-31$S$4.17 B24.61%
2019-12-31$S$3.34 B5.46%
2018-12-31$S$3.17 B5.02%
2017-12-31$S$3.02 B22.22%
2016-12-31$S$2.47 B20.75%
2015-12-31$S$2.04 B26.03%
2014-12-31$S$1.62 B24.46%
2013-12-31$S$1.30 B5.61%
2012-12-31$S$1.23 B23.12%
2011-12-31$S$1.00 B12.73%
2010-12-31$S$0.89 B155.82%
2009-12-31$S$0.34 B37.74%
2008-12-31$S$0.25 B512.41%
2007-12-31$S$41.3 M